An Interlaboratory Comparison on the Characterization of a Sub-micrometer Polydisperse Particle Dispersion.
Journal
Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
13
08
2021
revised:
10
11
2021
accepted:
10
11
2021
pubmed:
23
11
2021
medline:
26
4
2022
entrez:
22
11
2021
Statut:
ppublish
Résumé
The measurement of polydisperse protein aggregates and particles in biotherapeutics remains a challenge, especially for particles with diameters of ≈ 1 µm and below (sub-micrometer). This paper describes an interlaboratory comparison with the goal of assessing the measurement variability for the characterization of a sub-micrometer polydisperse particle dispersion composed of five sub-populations of poly(methyl methacrylate) (PMMA) and silica beads. The study included 20 participating laboratories from industry, academia, and government, and a variety of state-of-the-art particle-counting instruments. The received datasets were organized by instrument class to enable comparison of intralaboratory and interlaboratory performance. The main findings included high variability between datasets from different laboratories, with coefficients of variation from 13 % to 189 %. Intralaboratory variability was, on average, 37 % of the interlaboratory variability for an instrument class and particle sub-population. Drop-offs at either end of the size range and poor agreement on maximum counts of particle sub-populations were noted. The mean distributions from an instrument class, however, showed the size-coverage range for that class. The study shows that a polydisperse sample can be used to assess performance capabilities of an instrument set-up (including hardware, software, and user settings) and provides guidance for the development of polydisperse reference materials.
Identifiants
pubmed: 34808214
pii: S0022-3549(21)00612-2
doi: 10.1016/j.xphs.2021.11.006
pmc: PMC9912188
mid: NIHMS1854479
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
699-709Subventions
Organisme : Intramural NIST DOC
ID : 9999-NIST
Pays : United States
Organisme : NCATS NIH HHS
ID : R44 TR001590
Pays : United States
Informations de copyright
Copyright © 2021. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: N. Do is an employee of Spectradyne LLC, which manufactures and sells microfluidic resistive pulse sensing-based instrumentation for particle quantification. D. Grier is a founder of Spheryx, Inc., the company that manufactures the xSight instrument that was used for part of the NYU study. J. Hadley was employed at Malvern Panalytical, which develops and sells the Archimedes and LM10, LM14, LM20, NS300, and NS500 instruments used in this study. C. Probst was employed by Luminex Corporation, the manufacturer of the Amnis® CellStream® and FlowSight® that were used in this study. During this study J. Tatarkiewicz was employed by MANTA Instruments, Inc. which since then was acquired by HORIBA Scientific, Inc. The measurements were done using ViewSizer 3000 instrument. Alpha Nano Tech LLC is a Contract Research Organization; it has actual contracts with Particle Metrix Inc., as well as with other instruments vendors, and provides services for the companies on request. In general, Alpha Nano Tech LLC has contracts with Particle Metrix and special terms on acquiring instruments. Alpha Nano Tech provides services on variety of instruments/techniques, including those which compete with each other. Spheryx Inc. sells the Holographic Characterization Instrument (xSight and xCell8) used in this publication. We also hold the patents associated to this technology. Yokogawa Fluid Imaging Technologies, Inc. develops and sells the FlowCam® Nano flow imaging microscope used in this study. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Pharm Sci. 2015 Feb;104(2):666-77
pubmed: 25421933
J Nanopart Res. 2013;15:2101
pubmed: 24348090
Int J Pharm. 2020 Jul 30;585:119523
pubmed: 32531452
J Pharm Sci. 2012 Oct;101(10):3568-79
pubmed: 22736521
J Pharm Sci. 2020 Jan;109(1):830-844
pubmed: 31647951
J Pharm Sci. 2019 Jan;108(1):563-573
pubmed: 30176253
J Colloid Interface Sci. 2013 Sep 1;405:322-30
pubmed: 23759321
J Pharm Sci. 2012 Feb;101(2):493-8
pubmed: 21989781
Expert Opin Drug Deliv. 2016;13(2):167-70
pubmed: 26578092
Pharmaceutics. 2020 Nov 19;12(11):
pubmed: 33228023
Appl Opt. 2020 Mar 10;59(8):2337-2344
pubmed: 32225765
J Pharm Sci. 2009 Apr;98(4):1201-5
pubmed: 18704929
J Thromb Haemost. 2014 Jul;12(7):1182-92
pubmed: 24818656
J Extracell Vesicles. 2017 Jul 19;6(1):1344087
pubmed: 28804597
Curr Opin Biotechnol. 2014 Dec;30:211-7
pubmed: 25173826
J Pharm Sci. 2019 Jan;108(1):755-762
pubmed: 30237029
AAPS J. 2014 May;16(3):440-51
pubmed: 24570341
J Pharm Sci. 2016 Jul;105(7):2042-52
pubmed: 27287519
J Pharm Sci. 2015 Feb;104(2):750-9
pubmed: 25231267
Int J Pharm. 2012 Jul 15;431(1-2):1-11
pubmed: 22546296
J Pharm Sci. 2018 Nov;107(11):2847-2859
pubmed: 30003898
Eur J Pharm Biopharm. 2016 Jul;104:30-41
pubmed: 27108267
AAPS PharmSciTech. 2012 Jun;13(2):732-46
pubmed: 22566174